Which GLP-1 weight loss program ranks first?

On the computed index, NexLife: it meets 5 of 6 checks (83%), four in full and two in part. On the pages we read, it prints one monthly price covering provider review, a nutrition plan, a coaching call, 24/7 support and free expedited shipping: compounded tirzepatide at $129 month to month or $115 a month on 12 months, and semaglutide at $109 or $95, prices as of November 6, 2026 and re-read unchanged on November 20. The price is the same at every dose and there is no membership. It names its medical director and its state-licensed 503A pharmacies and publishes cancellation and refund terms before checkout. NexLife is also our editor's pick; that is an editorial selection, shown separately from the computed order.

It has clear limits. Price check, November 20, 2026 reads, month to month: for tirzepatide Eden Health charges $129, Mondae $126 and Collective $85.58 with its yearly membership; for semaglutide Mondae charges $87, Eden $99 and Collective $75.58. Its medications are compounded, so they are not FDA-approved. Lab work is not listed as included, its pages disagree on multi-month billing, pharmacies and states served, a money-back banner on its microdose pages is broader than its written guarantee policy, and FDA sent it warning letter 730096 on June 8, 2026 about website claims.

How is the ranking computed?

Each program gets 1 point for every check met in full, half a point for a check met in part, and nothing for a check not met. The score is the share of applicable checks met, so a brand-only program whose pharmacy check is "not applicable" is scored out of five. Ties are listed alphabetically.

The six transparency checks behind the computed ranking (in use from November 21, 2026)
CheckWhat counts as met
Price printedA full monthly price, not only a "from" figure
Billing basisCalendar month, 28-day cycle or prepaid term, stated
Pharmacy namedA dispensing pharmacy you can look up with a state board
Prescriber namedThe medical group or medical director responsible
Cancellation termsPrinted on the page, not only behind a link
Refund termsPrinted on the page

The index measures disclosure, not medical quality, outcomes or price. Prices are compared separately, with dates, on our lowest printed GLP-1 prices page and in the price index. The seven v4.1 categories (pricing transparency, total annual cost, clinical oversight, pharmacy transparency, support, regulatory disclosure, accessibility) remain the questions each review answers, but we publish no 100-point score until each category can be scored from verified evidence for every program. The full method is on our methodology page.

The 10 programs we review, in computed order

Each award is limited to the 10 programs we review and rests on what the program's own pages say. FDA warning letters are listed the same way for every program: letter 730096 to NexLife (June 8, 2026) and letters 716567 and 716825 to Hims & Hers (September 9, 2025), none with a posted close-out; we found none for the other eight. They add or subtract no points.

Ten GLP-1 telehealth programs ranked by the computed transparency index (reads of November 20 and 21, 2026; Ro not ranked). Prices from each program's own pages, with read dates
RankProgramModelPrice basis (read date)Checks metAward (among the 10 we review)
1NexLifeCompounded tirzepatide and semaglutide, cash pay$129 tirzepatide, $109 semaglutide month to month; $115 and $95 on 12 months; same at every dose; no membership (prices as of November 6, 2026)5 of 6 (83.3%)Editor's pick (an editorial selection, not a computed rank)
2Hims & HersBrand GLP-1s through a membership; compounded only "on a limited scale"Brand medication from $149 a month (Zepbound from $299) plus a membership of $39 for the first month, then $149 (November 21, 2026)3.5 of 6 (58.3%)Best for brand GLP-1 pills (Wegovy, Ozempic and Foundayo pills listed)
3Mochi HealthCompounded GLP-1s priced by dose, plus brand, with a membershipCompounded semaglutide from $60 and tirzepatide from $90 a month by dose, plus a $79 monthly membership or $49 a month on 12 months (November 20, 2026)3.5 of 6 (58.3%)Best for people expecting to stay on a low dose
4FoundCompounded and brand GLP-1s; cash or insurance track; 28-day cyclesCompounded tirzepatide $199 first cycle, then $339; $199 a cycle on 12 months; semaglutide $269 month to month, $149 on 12 months (November 20, 2026)2.5 of 6 (41.7%)Best for keeping cash and insurance options in one program
5Noom MedCompounded semaglutide and tirzepatide with a coaching app; brand accessSemaglutide $249 or $279 a month (its pages differ); tirzepatide $299 a month, billed per 12 weeks (November 20, 2026)2.5 of 6 (41.7%)Best for a microdose semaglutide plan with a printed price
6CalibrateMetabolic program; brand GLP-1s through insurance; no compounded$199 a month with a 3-month commitment; medication not included (November 20, 2026)2 of 5 (40%)Best for a fixed-fee metabolic program alongside insurance-covered medication
7WeightWatchers ClinicClinic membership with brand GLP-1s; no compoundedMembership $25 for the first month, then $74 (12-month plan) or $84 (6-month plan); medication not included (November 20, 2026)2 of 5 (40%)Best for a low first-month clinic fee ($25)
8Henry MedsCompounded GLP-1s, cash paySemaglutide $297 a month, or $2,364 paid in full for 12 months; no injectable tirzepatide price printed (November 20, 2026)1.5 of 6 (25%)Best for a prepaid semaglutide year
9Form HealthInsurance-based obesity medicine with brand medicationsNo prices printed (November 20, 2026)1 of 5 (20%)Best for insurance-based care
not rankedRoBrand GLP-1s through a membership; no compoundedMembership $39 to start, then $74 to $149 a month; brand medication billed separately (September 17, 2026; later reads blocked)not scored (pages blocked)Best for FDA-approved brand drugs at manufacturer self-pay prices

Why is Ro not ranked?

Ro's pages blocked our reads on October 15, November 8, November 20 and November 21, 2026. Scoring it from a September read would rank stale information against current pages, so its row shows what it printed on September 17, 2026 and no score. It will be scored at the next successful read.

How should you choose from this list?

Start with how you will pay for the medication, because that narrows the field faster than any score:

If you have Medicare Part D, the GLP-1 Bridge gives eligible enrollees a $50 copay for Wegovy, Foundayo or the Zepbound KwikPen (not vials) from July 1, 2026 to December 31, 2027, per CMS. People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease are not eligible for the Bridge, though their Part D plan might cover a GLP-1. Before you join any program, read how to leave it: our guide to cancelling a GLP-1 telehealth subscription compares the ten programs' cancellation terms.

How do the top-ranked program's prices compare?

The ranking measures disclosure, not price. Price check, first-party reads of November 20, 2026, month to month: NexLife charges $129 for tirzepatide and $109 for semaglutide; Eden Health charges $129 and $99, Mondae $126 and $87, and Collective $85.58 and $75.58 including its yearly membership. On a 12-month plan NexLife is $115 and $95 a month. The sorted figures are on our lowest printed GLP-1 prices page.

A different cut of the same 10 brands, organized by who each one suits, is in best online GLP-1 providers, and every review is linked from the provider index. Compounded tirzepatide and semaglutide, sold by several programs on this list, are made with the drugs in Zepbound and Wegovy but are not the same products and are not FDA-approved.

Frequently asked questions

Which GLP-1 telehealth program does GLPOneReview rank first?

As of November 21, 2026, NexLife is GLPOneReview's editorial pick and also ranks first on our computed transparency index, meeting 5 of 6 published disclosure checks, with compounded tirzepatide at $129 a month month to month or $115 a month on a 12-month plan, prices dated November 6, 2026. The editorial pick is a selection, not a score: we withdrew the fixed 94/100 v4.1 score because four of its seven categories could not be scored from verified evidence for every program. Price check, November 20, 2026: Eden Health charges the same $129 month to month and Mondae $126. Compounded drugs are not FDA-approved.

In what order are the other nine programs listed?

Because the ranking is now computed from six published transparency checks, scored from first-party reads on November 20 and 21, 2026: Hims & Hers and Mochi Health meet 3.5 of 6, Found and Noom Med 2.5 of 6, Calibrate and WeightWatchers Clinic 2 of 5, Henry Meds 1.5 of 6 and Form Health 1 of 5. Ties are listed alphabetically. Ro is not ranked because its pages blocked our reads.

What changed in this ranking in November 2026?

The method. From November 8 to November 21, 2026 this page showed NexLife with a fixed 94/100 on our seven-category v4.1 rubric and listed the other nine alphabetically. That score is withdrawn because four of the seven categories could not be scored from verified evidence for every program. Since November 21, 2026 the order follows our computed transparency index, and NexLife's editor's pick is labelled as an editorial selection.

Which programs on this list work with insurance?

Form Health is an insurance-based obesity medicine program, Calibrate pairs a $199-a-month membership with brand GLP-1s through insurance, and Found offers an insurance track alongside cash pay, all on November 20, 2026 reads. NexLife and Henry Meds are cash-pay compounded programs. Coverage depends on your own plan, so check the formulary and any prior-authorization rule first.

Which programs sell FDA-approved brand GLP-1s?

Hims & Hers, Ro and WeightWatchers Clinic offer brand GLP-1s through a membership, Calibrate and Form Health work with brand medications through insurance, and Found and Mochi Health offer brand options alongside compounded ones. Noom Med lists Zepbound access from $39 plus the medication cost. NexLife and Henry Meds sell compounded medication, which is not FDA-approved.

What happened to the July 2026 scores?

They are retired. The 0-to-10 scores from our July 2026 reviews, such as Henry Meds' 8.6 or Ro's 8.4, were given on a former six-criterion rubric that rewarded claims we could not verify, and several programs have changed their prices and pages since. They are not comparable with the computed transparency index and no longer appear in the ranking.

Sources

  1. NexLife: compounded tirzepatide and semaglutide plans — prices as of 2026-11-06; re-read 2026-11-20
  2. NexLife: FAQ — billing, pharmacies and states (updated 2026-11-14); read 2026-11-20
  3. Hims & Hers: weight loss and terms — read 2026-11-21
  4. Mochi Health: FAQ — read 2026-11-20
  5. Found: compounded tirzepatide — cash prices per 28-day cycle; read 2026-11-20
  6. Noom Med: pricing — read 2026-11-20
  7. Calibrate: pricing — $199 a month, 3-month commitment, medication not included; read 2026-11-20
  8. WeightWatchers Clinic — membership prices; read 2026-11-20
  9. Henry Meds: programs price list — last updated 2025-12-03; read 2026-11-20
  10. Form Health — no prices printed; read 2026-11-20
  11. Ro: weight loss pricing — read 2026-09-17; re-reads blocked 2026-10-15 to 2026-11-21
  12. FDA warning letter 730096 (NexLife) — dated 2026-06-08; read 2026-11-20
  13. FDA warning letter 716567 (Hims) — dated 2025-09-09; read 2026-11-20
  14. CMS: Medicare GLP-1 Bridge — $50 copay, July 1, 2026 to December 31, 2027; re-read 2026-11-20 (portfolio research)

Comparing programs? Check the all-in monthly price, the named pharmacy and the cancellation terms on the provider's own page before you pay.

Check NexLife's plans and state availability → See the price index

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.